At a time of record auto recalls and high-profile train wrecks, Republicans are working on legislation to roll back safety regulation of the auto and railroad industries.
Blue Cross and Blue Shield will be providing identity protection services to all eligible members across the U.S. by the start of the new year.
The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.
"Because International" is a nonprofit that has developed a new children's shoe that expands up to five sizes.
A CDC report shows a 63 percent increase in heroin use over the last decade.
Cancer specialist Dr. Farid Fata sat in a Michigan courtroom and listened to former patients describing how he ruined their lives.
Medicare proposed to ease a coverage policy on short hospital stays that has been criticized because it can result in higher costs for seniors.
The Supreme Court ruling validating federal health insurance subsidies for nearly 6.4 million Americans had consumers breathing a sigh of relief, but the reaction was different states states that have fought against the Affordable Care Act.
The pushback against soaring cancer drug prices is gaining steam. A leading doctors group proposed a formula to help patients decide if a medicine is worth it - what it will cost them and how much good it is likely to do.
Anthem sees its more than $47 billion bid to buy rival Cigna as a way to muscle up on technology that helps consumers and to strengthen its rapidly growing Medicare Advantage business.